NCT05115825

Brief Summary

This clinical trial improves an existing pain management program and tests its effect on head and neck cancer survivors. This trial aims to find a better program to improve pain-related physical functioning, mood, and quality of life in a sample of individuals who have undergone treatment for head and neck cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

October 29, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 10, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2025

Completed
Last Updated

February 27, 2026

Status Verified

January 1, 2026

Enrollment Period

5.6 years

First QC Date

October 29, 2021

Last Update Submit

February 25, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Pain-interference

    Will be assessed by Brief Pain Inventory. Will be assessed as 1-4=mild pain; 5-6 moderate pain; 7-10 severe pain.

    Up to 2 months

  • Depression

    Will be assessed by the Patient Health Questionnaire. Scores of 5, 10, 15, and 20 represent point scale for mild, moderate, moderately severe and severe depression, respectively.

    Up to 2 months

  • Pain coping self-efficacy

    Will be assessed by the Chronic Pain Self-Efficacy Scale.

    Up to 2 months

Secondary Outcomes (2)

  • Substance use

    Up to 2 months

  • Head and neck cancer related quality of life

    Up to 2 months

Other Outcomes (3)

  • Prescription opioid dose

    Up to 2 months

  • Prescription opioid misuse

    Up to 2 months

  • Patient acceptability

    Up to 2 months

Study Arms (1)

Supportive care (Mobile Pain Coping Skills Training)

EXPERIMENTAL

Patients attend 5 sessions of Mobile Pain Coping Skills Training for 45 minutes each over 8 weeks.

Behavioral: Behavioral InterventionOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Interventions

Attend Mobile Pain Coping Skills Training

Also known as: Behavior Conditioning Therapy, Behavior Modification, Behavior or Life Style Modifications, Behavior Therapy, Behavioral Interventions, Behavioral Modification, Behavioral Therapy, Behavioral Treatment, Behavioral Treatments
Supportive care (Mobile Pain Coping Skills Training)

Ancillary studies

Also known as: Quality of Life Assessment
Supportive care (Mobile Pain Coping Skills Training)

Ancillary studies

Supportive care (Mobile Pain Coping Skills Training)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically confirmed diagnosis of HNC for which the participants have completed curative cancer treatment at the VA hospital or Oregon Health \& Science University (OHSU) within the 3-12 months following treatment
  • Self-reported current pain of 4 or higher, using the 0-10 Numeric Pain Rating (NRS) (0="no pain" to 10="the worst pain imaginable")
  • Self-report of pain 4 or higher on two occasions, more than three weeks apart, since the completion of curative treatment

You may not qualify if:

  • Enrolled in hospice
  • Have substantial hearing or visual difficulties that would impair ability to participate
  • Have inadequate cognitive functioning as indicated by medical record review and/or interactions with clinical staff. If needed the investigators can follow up with the St. Louis University Mental State Examination (score of \< 22/30) (SLUMS); or
  • Have untreated severe psychiatric illness that would impact the ability to consent and participate in the intervention
  • Had only surgical treatment for their HNC

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

OHSU Knight Cancer Institute

Portland, Oregon, 97239, United States

Location

Portland VA Medical Center

Portland, Oregon, 97239, United States

Location

MeSH Terms

Interventions

Behavior Therapy

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Shannon Nugent, Ph.D.

    OHSU Knight Cancer Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 29, 2021

First Posted

November 10, 2021

Study Start

April 1, 2019

Primary Completion

October 30, 2024

Study Completion

May 16, 2025

Last Updated

February 27, 2026

Record last verified: 2026-01

Locations